Inclusion complex of α-lipoic acid and modified cyclodextrins

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 68, Issue 1, 2010, Pages 201-206

  Maeda, Hideko ^a   Onodera, Tomoko ^a   Nakayama, Hirokazu ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Lipoic acid; Inclusion complexes; Solubility; Sulfobutylether cyclodextrin

Indexed keywords

EID: 77956532400     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9767-7     Document Type: Article

References (20)

1. Sumathi, R., Jayanthi, S., Kalpanadevi, V., Varalakshmi, P.: Effect of DL α-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol. Res. 27, 309-317 (1993).
2. Packer, L., Witt, E. H., Tritschler, H. J.: Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19, 227-250 (1995).
3. Packer, L., Tritschler, H. J., Wessel, K.: Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radic. Biol. Med. 22, 359-378 (1997).
4. Jones, W., Li, X., Qu, Z.-C., Perriott, L., Whitesell, R. R., May, J. M.: Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radic. Biol. Med. 33, 83-93 (2002).
5. Ziegler, D., Schatz, H., Conrad, F., Gries, F. A., Ulrich, H., Reichel, G.: Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20, 369-373 (1997).
6. Packer, L., Kraemer, K., Rimbach, G.: Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17, 888-895 (2001).
7. Stevens, M. J., Obrosova, I., Cao, X., Huysen, C. V., Greene, D. A.: Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49, 1006-1015 (2000).
8. Saenger, W.: Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. Ed. Engl. 19, 344-362 (1980).
9. ÖZdemir, N., Ordu, Ş.: Improvement of dissolution properties of furosemide by complexation with β-cyclodextrin. Drug Dev. Ind. Pharm. 24, 19-25 (1998).
10. Uekama, K.: Pharmaceutical applications of methylated cyclodextrins. Pharm. Int. 6, 61-65 (1985).
11. Brewster, M. E., Estes, K. S., Loftsson, T., Perchalski, R., Derendorf, H., Mullersman, G., Bodor, N.: Improved delivery through biological membranes XXXI: solubilization and stabilization of an estradiol chemical delivery system by modified β-cyclodextrins. J. Pharm. Sci. 77, 981-985 (1988).
12. Szejtli, J.: The properties and potential uses of cyclodextrin derivatives. J. Incl. Phenom. Mol. Recognit. Chem. 14, 25-36 (1992).
13. Hirayama, F.: Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers. Yakugaku Zasshi 113, 425-437 (1993).
14. Junquera, E., Alcart, E.: Thermodynamic analysis of the binding of a hepatoprotectant drug, thioctic acid, by β-cyclodextrin. J. Pharm. Sci. 88, 626-631 (1999).
15. Trentin, M., Carofiglio, T., Fornasier, R., Tonellato, U.: Capillary zone electrophoresis study of cyclodextrin-lipoic acid host-guest interaction. Electrophoresis 23, 4117-4122 (2002).
16. Carofiglio, T., Fornasier, R., Jicsinszky, L., Saielli, G., Tonellato, U., Vetta, R.: Capillary electrophoresis, ROESY NMR and molecular modelling study of the inclusion complex β-cyclodextrin/lipoic acid. Eur. J. Org. Chem. 2002, 1191-1196 (2002).
17. Higuchi, T., Connors, K. A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965).
18. Irie, T., Uekama, K.: Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86, 147-162 (1997).
19. Thompson, D. O.: Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carr. Syst. 14, 1-104 (1997).
20. Tong, L.-H., Pang, Z.-Z., Yi, Y.: Inclusion complexes of α- and β-cyclodextrin with α-lipoic acid. J. Incl. Phenom. Mol. Recognit. Chem. 23, 119-126 (1995).